Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Relationship between DXA measured metrics of adiposity and glucose homeostasis; An analysis of the NHANES data.

Santhanam P, Rowe SP, Dias JP, Ahima RS.

PLoS One. 2019 May 22;14(5):e0216900. doi: 10.1371/journal.pone.0216900. eCollection 2019.

2.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.

Sahakyan K, Li X, Lodge MA, Werner RA, Bundschuh RA, Bundschuh L, Kulkarni HR, Schuchardt C, Baum RP, Pienta KJ, Pomper MG, Ross AE, Gorin MA, Rowe SP.

Mol Imaging Biol. 2019 May 21. doi: 10.1007/s11307-019-01376-9. [Epub ahead of print]

PMID:
31115751
3.

Response to R-CHOP in HPV-related squamous cell carcinoma of base of tongue: a case report.

Ma TM, Kang H, Rowe SP, Kiess AP.

Cancers Head Neck. 2018 May 24;3:2. doi: 10.1186/s41199-018-0028-6. eCollection 2018.

4.

No Mission, No Engagement.

Fishman EK, Chu LC, Rowe SP.

J Am Coll Radiol. 2019 May 14. pii: S1546-1440(19)30454-5. doi: 10.1016/j.jacr.2019.04.012. [Epub ahead of print] No abstract available.

PMID:
31092341
5.

Computed Tomography Cinematic Rendering in the Evaluation of Colonic Pathology: Technique and Clinical Applications.

Rowe SP, Chu LC, Fishman EK.

J Comput Assist Tomogr. 2019 May 6. doi: 10.1097/RCT.0000000000000864. [Epub ahead of print]

PMID:
31082979
6.

Computed Tomography Cinematic Rendering in the Evaluation of Colonic Pathology: Technique and Clinical Applications.

Rowe SP, Chu LC, Fishman EK.

J Comput Assist Tomogr. 2019 May/Jun;43(3):475-484. doi: 10.1097/RCT.0000000000000864.

PMID:
31082955
7.

Cinematic rendering of focal liver masses.

Chu LC, Rowe SP, Fishman EK.

Diagn Interv Imaging. 2019 Apr 29. pii: S2211-5684(19)30091-9. doi: 10.1016/j.diii.2019.04.003. [Epub ahead of print]

PMID:
31047840
8.

Soft Tissue Calcinosis Universalis Visualized with Novel 3-D Computed Tomography Cinematic Rendering.

Rowe SP, Fritz J, Fishman EK.

J Rheumatol. 2019 May;46(5):539-540. doi: 10.3899/jrheum.180208. No abstract available.

PMID:
31043499
9.

Learning to Talk Again in a Voice-First World.

Isbitski D, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 Apr 13. pii: S1546-1440(19)30139-5. doi: 10.1016/j.jacr.2019.01.034. [Epub ahead of print] No abstract available.

PMID:
30987902
10.

3D CT cinematic rendering of the spleen: Potential role in problem solving.

Rowe SP, Chu LC, Fishman EK.

Diagn Interv Imaging. 2019 Mar 27. pii: S2211-5684(19)30062-2. doi: 10.1016/j.diii.2019.03.005. [Epub ahead of print]

PMID:
30928470
11.

Cinematic Rendering of Neurofibromatosis Type I Gastrointestinal Stromal Tumors.

Rowe SP, Fishman EK.

Radiology. 2019 May;291(2):298. doi: 10.1148/radiol.2019190104. Epub 2019 Mar 19. No abstract available.

PMID:
30888936
12.

18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.

Sheikhbahaei S, Jones KM, Werner RA, Salas-Fragomeni RA, Marcus CV, Higuchi T, Rowe SP, Solnes LB, Javadi MS.

Ann Nucl Med. 2019 May;33(5):351-361. doi: 10.1007/s12149-019-01343-y. Epub 2019 Mar 15.

PMID:
30877561
13.

Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel 18F-labeled PET radiotracers.

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T.

Trends Cardiovasc Med. 2019 Feb 20. pii: S1050-1738(19)30025-8. doi: 10.1016/j.tcm.2019.02.007. [Epub ahead of print] Review.

14.

Novel Structured Reporting Systems for Theranostic Radiotracers.

Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP.

J Nucl Med. 2019 May;60(5):577-584. doi: 10.2967/jnumed.118.223537. Epub 2019 Feb 22.

PMID:
30796171
15.

Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT.

Gomez E, Tran PT, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Clin Nucl Med. 2019 Apr;44(4):e313-e314. doi: 10.1097/RLU.0000000000002489.

PMID:
30789396
16.

Novel Functional Renal PET Imaging With 18F-FDS in Human Subjects.

Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T.

Clin Nucl Med. 2019 May;44(5):410-411. doi: 10.1097/RLU.0000000000002494.

PMID:
30762825
17.

PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework.

Reyes DK, Demehri S, Werner RA, Pomper MG, Gorin MA, Rowe SP, Pienta KJ.

Urol Case Rep. 2019 Jan 9;23:72-74. doi: 10.1016/j.eucr.2019.01.007. eCollection 2019 Mar.

18.

Imaging of Prostate-Specific Membrane Antigen with Small-Molecule PET Radiotracers: From the Bench to Advanced Clinical Applications.

Rowe SP, Gorin MA, Pomper MG.

Annu Rev Med. 2019 Jan 27;70:461-477. doi: 10.1146/annurev-med-062117-073027.

PMID:
30691373
19.

Three-dimensional computed tomography cinematic rendering of mandibular odontogenic myxofibroma.

Rowe SP, Fishman EK.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jan 2. pii: S2212-4403(18)31348-8. doi: 10.1016/j.oooo.2018.12.022. [Epub ahead of print]

PMID:
30665843
20.

The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?

Werner RA, Weich A, Kircher M, Solnes LB, Javadi MS, Higuchi T, Buck AK, Pomper MG, Rowe SP, Lapa C.

Theranostics. 2018 Nov 29;8(22):6088-6100. doi: 10.7150/thno.30357. eCollection 2018. Review.

21.

Generative Adversarial Networks for the Creation of Realistic Artificial Brain Magnetic Resonance Images.

Kazuhiro K, Werner RA, Toriumi F, Javadi MS, Pomper MG, Solnes LB, Verde F, Higuchi T, Rowe SP.

Tomography. 2018 Dec;4(4):159-163. doi: 10.18383/j.tom.2018.00042.

22.

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Tucker EW, Guglieri-Lopez B, Ordonez AA, Ritchie B, Klunk MH, Sharma R, Chang YS, Sanchez-Bautista J, Frey S, Lodge MA, Rowe SP, Holt DP, Gobburu JVS, Peloquin CA, Mathews WB, Dannals RF, Pardo CA, Kannan S, Ivaturi VD, Jain SK.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau0965. doi: 10.1126/scitranslmed.aau0965.

PMID:
30518610
23.

Simplifying Complexity: Lessons for Radiology From a New Type of Stock Exchange.

Lam G, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2019 Apr;16(4 Pt A):536-538. doi: 10.1016/j.jacr.2018.09.046. Epub 2018 Nov 14. No abstract available.

PMID:
30447933
24.

Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.

Joice GA, Rowe SP, Gorin MA, Pierorazio PM.

Curr Urol Rep. 2018 Nov 9;19(12):110. doi: 10.1007/s11934-018-0863-3. Review.

PMID:
30413968
25.

Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution.

Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP.

Mol Imaging Biol. 2018 Nov 7. doi: 10.1007/s11307-018-1293-9. [Epub ahead of print]

PMID:
30406512
26.

Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging.

Werner RA, Marcus C, Sheikhbahaei S, Solnes LB, Leal JP, Du Y, Rowe SP, Higuchi T, Buck AK, Lapa C, Javadi MS.

Clin Nucl Med. 2019 Jan;44(1):1-3. doi: 10.1097/RLU.0000000000002333.

PMID:
30371577
27.

Moving into the next era of PET myocardial perfusion imaging: introduction of novel 18F-labeled tracers.

Werner RA, Chen X, Rowe SP, Lapa C, Javadi MS, Higuchi T.

Int J Cardiovasc Imaging. 2019 Mar;35(3):569-577. doi: 10.1007/s10554-018-1469-z. Epub 2018 Oct 17. Review.

28.

Uptake of Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL in Cerebral Radionecrosis: Implications for Diagnostic Imaging of High-Grade Gliomas.

Salas Fragomeni RA, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

Clin Nucl Med. 2018 Nov;43(11):e419-e421. doi: 10.1097/RLU.0000000000002280.

PMID:
30247210
29.

3D CT cinematic rendering of mycotic aneurysms.

Rowe SP, Chu LC, Zimmerman SL, Fishman EK.

Emerg Radiol. 2018 Dec;25(6):723-728. doi: 10.1007/s10140-018-1643-6. Epub 2018 Sep 19.

PMID:
30232634
30.

Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT.

Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA.

Mol Imaging Biol. 2019 Jun;21(3):567-573. doi: 10.1007/s11307-018-1271-2.

PMID:
30218388
31.

Volumetric and texture analysis of pretherapeutic 18F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib.

Werner RA, Bundschuh RA, Higuchi T, Javadi MS, Rowe SP, Zsótér N, Kroiss M, Fassnacht M, Buck AK, Kreissl MC, Lapa C.

Endocrine. 2019 Feb;63(2):293-300. doi: 10.1007/s12020-018-1749-3. Epub 2018 Sep 11.

32.

Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on 18F-DCFPyL PET/CT Imaging.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Leal JP, Higuchi T, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP.

J Nucl Med. 2018 Dec;59(12):1857-1864. doi: 10.2967/jnumed.118.217588. Epub 2018 Sep 6.

PMID:
30190304
33.

Follow-up of Lesions with Equivocal Radiotracer Uptake on PSMA-Targeted PET in Patients with Prostate Cancer: Predictive Values of the PSMA-RADS-3A and PSMA-RADS-3B Categories.

Yin Y, Werner RA, Higuchi T, Lapa C, Pienta KJ, Pomper MG, Gorin MA, Rowe SP.

J Nucl Med. 2019 Apr;60(4):511-516. doi: 10.2967/jnumed.118.217653. Epub 2018 Sep 6.

PMID:
30190303
34.

Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer.

Meyer AR, Joice GA, Allaf ME, Rowe SP, Gorin MA.

Curr Opin Urol. 2018 Nov;28(6):493-498. doi: 10.1097/MOU.0000000000000549.

PMID:
30188333
35.

SPECT vs. PET in cardiac innervation imaging: clash of the titans.

Werner RA, Chen X, Hirano M, Rowe SP, Lapa C, Javadi MS, Higuchi T.

Clin Transl Imaging. 2018;6(4):293-303. doi: 10.1007/s40336-018-0289-4. Epub 2018 Jul 3. Review.

36.

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.

Rowe SP, Luber B, Makell M, Brothers P, Santmyer J, Schollenberger MD, Quinn H, Edelstein DL, Jones FS, Bleich KB, Sharfman WH, Lipson EJ.

Mol Oncol. 2018 Oct;12(10):1661-1672. doi: 10.1002/1878-0261.12373. Epub 2018 Sep 8.

37.

Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications.

Werner RA, Bundschuh RA, Bundschuh L, Javadi MS, Higuchi T, Weich A, Sheikhbahaei S, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Lapa C, Rowe SP.

Ann Nucl Med. 2018 Oct;32(8):512-522. doi: 10.1007/s12149-018-1291-7. Epub 2018 Aug 14. Review.

38.

Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy.

Srivastava A, Meyer AR, Pierorazio PM, Rowe SP, Allaf ME, Gorin MA.

Clin Genitourin Cancer. 2018 Dec;16(6):e1083-e1085. doi: 10.1016/j.clgc.2018.07.012. Epub 2018 Jul 21. No abstract available.

PMID:
30097254
39.

Adding value to myocardial perfusion SPECT/CT studies that include coronary calcium CT: Detection of incidental pulmonary arterial dilatation.

Marcus C, Santhanam P, Kruse MJ, Javadi MS, Solnes LB, Rowe SP.

Medicine (Baltimore). 2018 Aug;97(32):e11359. doi: 10.1097/MD.0000000000011359.

40.

The emerging role of imaging in prostate cancer secondary screening: multiparametric magnetic resonance imaging and the incipient incorporation of molecular imaging.

Azadi J, Nguyen ML, Leroy A, Macura KJ, Gorin MA, Rowe SP.

Br J Radiol. 2018 Oct;91(1090):20170960. doi: 10.1259/bjr.20170960. Epub 2018 Jul 26. Review.

PMID:
30048145
41.

Meet Generation Z: Top 10 Trends of 2018.

Wells T, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2018 Dec;15(12):1791-1793. doi: 10.1016/j.jacr.2018.05.033. Epub 2018 Jul 21. No abstract available.

PMID:
30041949
42.

The Incipient Digital Revolution in Hospitality and Health Care: Digital Is Hospitable.

King B, Fishman EK, Horton KM, Rowe SP.

J Am Coll Radiol. 2018 Sep;15(9):1351-1353. doi: 10.1016/j.jacr.2018.05.013. Epub 2018 Jul 18. No abstract available.

PMID:
30031613
43.

Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.

Panigrahi B, Jones BC, Rowe SP.

Emerg Radiol. 2018 Dec;25(6):715-718. doi: 10.1007/s10140-018-1628-5. Epub 2018 Jul 18.

PMID:
30022308
44.

What the radiologist needs to know: the role of preoperative computed tomography in selection of operative approach for adrenalectomy and review of operative techniques.

Rowe SP, Lugo-Fagundo C, Ahn H, Fishman EK, Prescott JD.

Abdom Radiol (NY). 2019 Jan;44(1):140-153. doi: 10.1007/s00261-018-1669-y.

PMID:
29967985
45.

Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.

Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP.

AJR Am J Roentgenol. 2018 Aug;211(2):286-294. doi: 10.2214/AJR.18.19957. Epub 2018 Jun 27. Review.

PMID:
29949419
46.

What Health Care Can Learn From Self-Driving Vehicles.

Powell K, Fishman EK, Horton KM, Johnson PT, Rowe SP.

J Am Coll Radiol. 2019 Feb;16(2):261-263. doi: 10.1016/j.jacr.2018.04.022. Epub 2018 May 31. No abstract available.

PMID:
29861124
47.

Evaluation of Stomach Neoplasms With 3-Dimensional Computed Tomography: Focus on the Potential Role of Cinematic Rendering.

Rowe SP, Chu LC, Fishman EK.

J Comput Assist Tomogr. 2018 Sep/Oct;42(5):661-666. doi: 10.1097/RCT.0000000000000761. Review.

PMID:
29787502
48.

Launching a Successful Startup: An Entrepreneur's Field Guide.

Snepar J, Fishman EK, Horton KM, Johnson PT, Rowe SP.

J Am Coll Radiol. 2018 Oct;15(10):1521-1522. doi: 10.1016/j.jacr.2018.02.034. Epub 2018 May 18. No abstract available.

PMID:
29784625
49.

3D CT of renal pathology: initial experience with cinematic rendering.

Rowe SP, Meyer AR, Gorin MA, Johnson PT, Fishman EK.

Abdom Radiol (NY). 2018 Dec;43(12):3445-3455. doi: 10.1007/s00261-018-1644-7. Review.

PMID:
29779157
50.

A Voice From the Past: Rediscovering the Virchow Node With Prostate-specific Membrane Antigen-targeted 18F-DCFPyL Positron Emission Tomography Imaging.

Werner RA, Andree C, Javadi MS, Lapa C, Buck AK, Higuchi T, Pomper MG, Gorin MA, Rowe SP, Pienta KJ.

Urology. 2018 Jul;117:18-21. doi: 10.1016/j.urology.2018.03.030. Epub 2018 Apr 4. No abstract available.

Supplemental Content

Support Center